Aleix Prat
AuthID: R-00J-2A7
1
TITLE: PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
AUTHORS: Curigliano, Giuseppe; Cardoso, Fatima; Gnant, Michael; Harbeck, Nadia; King, Judy; Laenkholm, Anne Vibeke; Penault Llorca, Frederique; Prat, Aleix;
PUBLISHED: 2023, SOURCE: NPJ BREAST CANCER, VOLUME: 9, ISSUE: 1
AUTHORS: Curigliano, Giuseppe; Cardoso, Fatima; Gnant, Michael; Harbeck, Nadia; King, Judy; Laenkholm, Anne Vibeke; Penault Llorca, Frederique; Prat, Aleix;
PUBLISHED: 2023, SOURCE: NPJ BREAST CANCER, VOLUME: 9, ISSUE: 1
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+breast cancer: a plain language summary of the PHERGain study
AUTHORS: Perez Garcia, Jose Manuel; Gebhart, Geraldine; Borrego, Manuel Ruiz; Schmid, Peter; Marme, Frederik; Prat, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofia; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio;
PUBLISHED: 2022, SOURCE: FUTURE ONCOLOGY
AUTHORS: Perez Garcia, Jose Manuel; Gebhart, Geraldine; Borrego, Manuel Ruiz; Schmid, Peter; Marme, Frederik; Prat, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofia; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio;
PUBLISHED: 2022, SOURCE: FUTURE ONCOLOGY
INDEXED IN: WOS
WOS3
TITLE: Chemotherapy (CT) de-escalation using an FDG-PET/CT (F-PET) and pathological response-adapted strategy in HER2[+] early breast cancer (EBC): PHERGain Trial.
AUTHORS: Javier Cortes; Geraldine Gebhart; Manuel Ruiz Borrego; Agostina Stradella; Begona Bermejo; Santiago Escriva; Lourdes Calvo Martinez; Nuria Ribelles; Noelia Martinez; Cinta Albacar; Aleix Prat; Florence Dalenc; Kerrou Khaldoun; Peter Schmid; Marco Colleoni; Frederik Marme; Noemia Afonso; Miguel Sampayo Cordero; Jose Manuel Perez Garcia; Antonio Llombart Cussac;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
AUTHORS: Javier Cortes; Geraldine Gebhart; Manuel Ruiz Borrego; Agostina Stradella; Begona Bermejo; Santiago Escriva; Lourdes Calvo Martinez; Nuria Ribelles; Noelia Martinez; Cinta Albacar; Aleix Prat; Florence Dalenc; Kerrou Khaldoun; Peter Schmid; Marco Colleoni; Frederik Marme; Noemia Afonso; Miguel Sampayo Cordero; Jose Manuel Perez Garcia; Antonio Llombart Cussac;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
INDEXED IN: WOS
WOS4
TITLE: What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?
AUTHORS: Mariana Brandão ; Rafael Caparica; Luca Malorni; Aleix Prat; Lisa A Carey; Martine Piccart;
PUBLISHED: 2020, SOURCE: Clinical Cancer Research, VOLUME: 26, ISSUE: 12
AUTHORS: Mariana Brandão ; Rafael Caparica; Luca Malorni; Aleix Prat; Lisa A Carey; Martine Piccart;
PUBLISHED: 2020, SOURCE: Clinical Cancer Research, VOLUME: 26, ISSUE: 12
5
TITLE: Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial Full Text
AUTHORS: Matteo Lambertini; Christine Campbell; Richard D Gelber; Giuseppe Viale; Ann McCullough; Florentine Hilbers; Larissa A Korde; Olena Werner; Saranya Chumsri; Christian Jackisch; Antonio C Wolff; Ines Vaz Luis; Arlindo R Ferreira; Aleix Prat; Alvaro Moreno Aspitia; Martine Piccart; Sherene Loi; Evandro de Azambuja;
PUBLISHED: 2019, SOURCE: BREAST CANCER RESEARCH AND TREATMENT, VOLUME: 177, ISSUE: 1
AUTHORS: Matteo Lambertini; Christine Campbell; Richard D Gelber; Giuseppe Viale; Ann McCullough; Florentine Hilbers; Larissa A Korde; Olena Werner; Saranya Chumsri; Christian Jackisch; Antonio C Wolff; Ines Vaz Luis; Arlindo R Ferreira; Aleix Prat; Alvaro Moreno Aspitia; Martine Piccart; Sherene Loi; Evandro de Azambuja;
PUBLISHED: 2019, SOURCE: BREAST CANCER RESEARCH AND TREATMENT, VOLUME: 177, ISSUE: 1
INDEXED IN: Scopus WOS
Scopus WOS